July 12, 2014 7:36 PM ET

Pharmaceuticals

Company Overview of Alkaloida Chemical Company Zrt

Executive Profile

Timothy C. Tyson

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 7 different industries.

See Board Relationships
62--

Background

Mr. Timothy C. Tyson, also known as Tim, has been the Interim Chief Executive Officer and Executive Chairman of Aptuitand at Laurus Labs Private Limite since August 2008. Mr. Tyson serves as the President of Alkaloida Chemical Company Zrt. He has over 30 years of remarkable corporate career in the pharmaceutical industry. He served as Acting Chief Executive Officer of Aptuit LLC since September 2008. He served as the President of ICN Hungary Co., Ltd. (also called as ...

Corporate Headquarters

Kabay János út 29.
Tiszavasvári, -- 4440

Hungary

Phone: 36 42 275 511
Fax: 36 42 372 512

Board Members Memberships

Director
Chairman
President and Director
2004-2008
Former Chief Executive Officer, President and Director
2013-Present
Independent Director
2013-Present
Independent Non-Executive Chairman, Member of Compensation Committee and Member of Nominating Committee

Education

Unknown/Other Education 1974
United States Military Academy
Master's Degree 1976
Jacksonville State University
MBA 1979
Jacksonville State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Indra K. Nooyi M.P.P.M.Chairman and Chief Executive Officer
Pepsico, Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
$2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
$15.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alkaloida Chemical Company Zrt, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.